MARKET TALK: GlaxoSmithKline Shrs Nudge Tad Higher On 1H Data

21st Jul 2010 12:14

1114 GMT [Dow Jones] GlaxoSmithKline (GSK.LN) +0.4% at 1178.0p, nudging just a tad higher following its half-year report. A trader says there are no major surprises in the release. Previous 2010 cost guidance - cost of sales, selling, general and administrative expenses and R&D - is confirmed in the report. The trader notes 2Q EPS of 2.6p is distorted by the company's pre-announced legal charge. EPS would otherwise have come in at 29.3p excluding the legal charge. ([email protected]) Contact us in London. +44-20-7842-9464 [email protected] (END) Dow Jones Newswires July 21, 2010 07:14 ET (11:14 GMT)

Top Risers

Share	Price	Change
Huddled Group (HUD)	0.85	24.14%
Eurasia Mining (EUA)	2.80	19.15%
Genincode (GENI)	0.725	16%
Medpal AI (MPAL)	5.25	14.13%
Light Science Technologies (LST)	0.875	12.9%

Top Fallers

Share	Price	Change
Catenai Plc (CTAI)	0.0575	-39.47%
Petra Diamonds (PDL)	2.60	-26.14%
Focus Xplore (FOX)	0.019	-22.45%
Litigation Cap. (LIT)	0.301	-20.12%
Abrdn Property (API)	1.52	-15.56%

Top By Volume

Share	Price	Volume
Ethernity Net (ENET)	0.0019	1,922,336,250
Forgent (FORG)	0.0115	591,087,829
Premier African Minerals (PREM)	0.0044	313,776,718
Focus Xplore (FOX)	0.019	253,421,870
Bezant Resources PLC (BZT)	0.11	246,929,868

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.